A citation-based method for searching scientific literature

Thomas B Silverman, Alejandro Vanegas, Awilda Marte, Jennie Mata, Margaret Sin, Juan Carlos Rodriguez Ramirez, Wei-Yann Tsai, Katherine D Crew, Rita Kukafka. BMC Health Serv Res 2018
Times Cited: 6

List of co-cited articles
33 articles co-cited >1

Times Cited
  Times     Co-cited

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005

Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting.
Rita Kukafka, Jiaqi Fang, Alejandro Vanegas, Thomas Silverman, Katherine D Crew. BMC Med Inform Decis Mak 2018

Integrating tools for breast cancer risk assessment, risk reduction, and early detection.
Elizabeth M Ward, Robert A Smith. Cancer Epidemiol Biomarkers Prev 2010

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006

Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.
Katie E J Hann, Madeleine Freeman, Lindsay Fraser, Jo Waller, Saskia C Sanderson, Belinda Rahman, Lucy Side, Sue Gessler, Anne Lanceley. BMC Public Health 2017

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019

Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer.
Robert A Bell, Haley McDermott, Tonya L Fancher, Michael J Green, Frank C Day, Michael S Wilkes. J Gen Intern Med 2015

Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
Julia E McGuinness, William Ueng, Meghna S Trivedi, Hae Seung Yi, Raven David, Alejandro Vanegas, Jennifer Vargas, Rossy Sandoval, Rita Kukafka, Katherine D Crew. Cancer Epidemiol Biomarkers Prev 2018

Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
Douglas J Rupert, Linda B Squiers, Jeanette M Renaud, Nedra S Whitehead, Roger J Osborn, Robert D Furberg, Claudia M Squire, Janice P Tzeng. Patient Educ Couns 2013

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
S R Cummings, S Eckert, K A Krueger, D Grady, T J Powles, J A Cauley, L Norton, T Nickelsen, N H Bjarnason, M Morrow,[...]. JAMA 1999

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.
Celia Patricia Kaplan, Jennifer S Haas, Eliseo J Pérez-Stable, Steven E Gregorich, Carol Somkin, Genevieve Des Jarlais, Karla Kerlikowske. Cancer Epidemiol Biomarkers Prev 2006

Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.
Angela Fagerlin, Amanda J Dillard, Dylan M Smith, Brian J Zikmund-Fisher, Rosemarie Pitsch, Jennifer B McClure, Sarah Greene, Sharon Hensley Alford, Vijayan Nair, Daniel F Hayes,[...]. Breast Cancer Res Treat 2011

Personalised risk communication for informed decision making about taking screening tests.
Adrian G K Edwards, Gurudutt Naik, Harry Ahmed, Glyn J Elwyn, Timothy Pickles, Kerry Hood, Rebecca Playle. Cochrane Database Syst Rev 2013

Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
Angela Fagerlin, Brian J Zikmund-Fisher, Vijayan Nair, Holly A Derry, Jennifer B McClure, Sarah Greene, Azadeh Stark, Sharon Hensley Alford, Paula Lantz, Daniel F Hayes,[...]. Breast Cancer Res Treat 2010

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Sharon L Bober, Lizbeth A Hoke, Rosemary B Duda, Meredith M Regan, Nadine M Tung. J Clin Oncol 2004

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Jack Cuzick, John F Forbes, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell. J Natl Cancer Inst 2007

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011

Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Christian R Loehberg, Sebastian M Jud, Lothar Haeberle, Katharina Heusinger, Gerhard Dilbat, Alexander Hein, Claudia Rauh, Peter Dall, Nadine Rix, Sabrina Heinrich,[...]. Breast Cancer Res Treat 2010

Breast biopsy and race/ethnicity among women without breast cancer.
Judith S Jacobson, Victor R Grann, Dawn Hershman, Andrea B Troxel, Huiling Li, Alfred I Neugut. Cancer Detect Prev 2006

"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital.
Talya Salant, Pamela S Ganschow, Olufunmilayo I Olopade, Diane S Lauderdale. J Gen Intern Med 2006

Patient reluctance toward tamoxifen use for breast cancer primary prevention.
E R Port, L L Montgomery, A S Heerdt, P I Borgen. Ann Surg Oncol 2001

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Joy Melnikow, Debora Paterniti, Rahman Azari, Christina Kuenneth, Stephen Birch, Miriam Kuppermann, James Nuovo, Janet Keyzer, Stuart Henderson. Cancer 2005

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Trevor J Powles, Sue Ashley, Alwynne Tidy, Ian E Smith, Mitch Dowsett. J Natl Cancer Inst 2007

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.
Umberto Veronesi, Patrick Maisonneuve, Nicole Rotmensz, Bernardo Bonanni, Peter Boyle, Giuseppe Viale, Alberto Costa, Virgilio Sacchini, Roberto Travaglini, Giuseppe D'Aiuto,[...]. J Natl Cancer Inst 2007

Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
Ida J Korfage, Andrea Fuhrel-Forbis, Peter A Ubel, Brian J Zikmund-Fisher, Sarah M Greene, Jennifer B McClure, Dylan M Smith, Sharon Hensley Alford, Angela Fagerlin. Breast Cancer Res 2013

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019

Coherence and completeness of population-based family cancer reports.
Louise Wideroff, Anne O Garceau, Mark H Greene, Marsha Dunn, Timothy McNeel, Phuong Mai, Gordon Willis, Lou Gonsalves, Michael Martin, Barry I Graubard. Cancer Epidemiol Biomarkers Prev 2010

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011

The comprehensiveness of family cancer history assessments in primary care.
Harvey J Murff, Robert A Greevy, Sapna Syngal. Community Genet 2007

What Is the Effectiveness of Patient Decision Aids for Cancer-Related Decisions? A Systematic Review Subanalysis.
Kristen McAlpine, Krystina B Lewis, Lyndal J Trevena, Dawn Stacey. JCO Clin Cancer Inform 2018

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.
Ian M Collins, Adrian Bickerstaffe, Thilina Ranaweera, Sanjaya Maddumarachchi, Louise Keogh, Jon Emery, G Bruce Mann, Phyllis Butow, Prue Weideman, Emma Steel,[...]. Breast Cancer Res Treat 2016

Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
G Joseph, C Kaplan, J Luce, R Lee, S Stewart, C Guerra, R Pasick. Public Health Genomics 2012

Perceived cancer risk: why is it lower among nonwhites than whites?
Heather Orom, Marc T Kiviniemi, Willie Underwood, Levi Ross, Vickie L Shavers. Cancer Epidemiol Biomarkers Prev 2010

Confirmation of family cancer history reported in a population-based survey.
Phuong L Mai, Anne O Garceau, Barry I Graubard, Marsha Dunn, Timothy S McNeel, Lou Gonsalves, Mitchell H Gail, Mark H Greene, Gordon B Willis, Louise Wideroff. J Natl Cancer Inst 2011

Family history of cancer: is it an accurate indicator of cancer risk in the immigrant population?
Heather Orom, Michele L Coté, Hector M González, Willie Underwood, Ann G Schwartz. Cancer 2008

Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
Anita Yeomans Kinney, Amanda Gammon, James Coxworth, Sara E Simonsen, Maritza Arce-Laretta. Genet Med 2010

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018

A systematic review of factors that act as barriers to patient referral to genetic services.
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.